Mark Bruzzi

Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA.

Direct Flow Medical, Inc. develops transcatheter heart valve technologies. It explores application of its technology beyond the aortic valve, to the mitral valve, and other valve anatomy. The firm’s Transcatheter Aortic Valve System is indicated for the treatment of patients with severe aortic stenosis, who are at risk for surgical aortic valve replacement. The company's system incorporates a polymer frame, which is expanded using pressurized saline and contrast for placement, assessment and repositioning. Direct Flow Medical was founded by Gordon B. Bishop and Randall T. Lashinski in June 2004 and is headquartered in Santa Rosa, CA.

Corvion, Inc. is a pre-clinical stage medical device company that focuses on bringing fully implanted heart assist technology to the worldwide market for mechanical circulatory support. The company is based in Webster, TX. The company aims to improve patient outcomes and quality of life by developing a highly efficient implantable rotary blood pump that is three times more efficient than competitors, coupled with a robust and flexible transcutaneous charging technology. Corvion offers an option for end-stage heart failure that gives back freedom and no longer limits the quality of life. The company was founded by Greg S. Aber, who has been the CEO since incorporation.

Artio Medical, Inc. develops novel, endovascular medical devices for the treatment of peripheral and neurovascular diseases. Its products include Solus Gold, Solus Flex, Anuera, and Endura. The company was founded by William P. Whitaker and F. Nicholas Franano in 2013 and is headquartered in Fairway, KS.

Altaris Capital Partners LLC (Altaris Capital Partners) is a private equity firm founded by George Aitken-Davies and Daniel Tully in 2003. The firm is headquartered in New York.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

Paramit Corp. engages n the provision of medical devices and life science instruments. It offers PCB assembly, vpoke mechanical assembly, optics capabilities, test solutions, and post manufacturing services. The company was founded by Billoo Rataul in 1990 and is headquartered in Morgan Hill, CA.

Pulse Therapeutics, Inc. provides medical devices to destroy blood clots. Its devices help in treating the stroke, heart disease and other conditions. Its products include MED System which helps in dissolve blood clots. The company was founded by Francis M. Creighton and Rogers Ritter in 2008 and is headquartered in St. Louis, Mo.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

Euphrates Vascular, Inc. provides medical devices. It offers treatment addressing vascular occlusions related to vascular disease. The company is headquartered in St. Louis, MO.

CairnSurgical, Inc. engages in provision of patient-specific tools to guide surgical interventions for patients with cancer. It offers personalized solution, improve care services, and MRI derived localization and guidance. The company was founded by Richard Barth Jr., Keith Paulsen, and Venkat Krishnaswamy and is headquartered in Lebanon, NH.

Vitara Biomedical, Inc. engages in the biotechnology business. The company is headquartered in Philadelphia, PA.

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.